What are the reasons for the strikingly different approaches to the use of ACTH in infants with West syndrome?

Brain and Development

Volumn 23, Issue 7, 2001, Pages 647-648

  Baram, Tallie Z ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACTHARGEL; Adenocorticotropic hormone; Clinical; Infantile spasms; West syndrome

Indexed keywords

ACTHARGEL; CORTICOTROPIN; MELANOCORTIN RECEPTOR; UNCLASSIFIED DRUG; VIGABATRIN;

CONFERENCE PAPER; DRUG DOSE; DRUG EFFICACY; DRUG MANUFACTURE; HEREDITY; HUMAN; INFANT; TUBEROUS SCLEROSIS; WEST SYNDROME;

ADRENOCORTICOTROPIC HORMONE; HUMANS; INFANT; SPASMS, INFANTILE;

EID: 0034777988     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00308-4     Document Type: Conference Paper

References (14)

1. Double-blind study of ACTH vs prednisone therapy in infantile spasms
2. Infantile spasms
3. A pilot study of topiramate in the treatment of infantile spasms
4. ACTH therapy for infantile spasms: a combination therapy with high-dose pyridoxal phosphate and low-dose ACTH
5. Vitamin B6 and valproic acid in treatment of infantile spasms
6. High dose ACTH versus prednisone for massive infantile spasms: a prospective randomized blinded study
7. Treatment of infantile spasms
8. Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy
9. A comparative study of high-dose and low-dose ACTH therapy for West syndrome
10. Treatment of infantile spasms with long-term low dose ACTH
11. A study on ACTH dosage for treatment of West syndrome
12. ACTH acts directly on amygdala neurons to down-regulate corticotropin releasing hormone gene expression
13. West syndrome: individualized ACTH therapy
14. Pathophysiology of massive infantile spasms (MIS): perspective on the role of the brain adrenal axis